Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-25, Stock:LLY, The news for the past five days is as follows:
2021-05-18: NEWS1: Lilly's (LLY) Tyvyt BLA Accepted for Review by FDA for NSCLC.NEWS2: Lilly-Innovent's Sintilimab Plus Chemo Application For Lung Cancer Under Review With FDA.NEWS3: U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer.
2021-05-19: NEWS1: Lilly Announces Details of Presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.NEWS2: New Strong Sell Stocks for May 19th.
2021-05-20: NEWS1: Eli Lilly's Tirzepatide Non-Inferior To Titrated Insulin Glargine In Type 2 Diabetes Patients.NEWS2: Lilly's tirzepatide achieves all primary and key secondary study outcomes against insulin glargine in adults with type 2 diabetes and increased cardiovascular risk in SURPASS-4 trial.
2021-05-21: NEWS1: Pharma Stock Roundup: GSK/SNY COVID-19 Vaccine Data, PFE's New EU Supply Deal.NEWS2: Lilly's (LLY) Fifth Tirzepatide Study Meets All Key Endpoints.
2021-05-24: NEWS1: Glaxo (GSK)/ Vir Biotech's COVID-19 Antibody Gets CHMP Nod.NEWS2: Eli Lilly's Mirikizumab Improves Fatigue in Crohn's Disease Patients.NEWS3: The Zacks Analyst Blog Highlights: Sanofi, GlaxoSmithKline, Pfizer, Eli Lilly and Merck.

Answer: Decrease